Breakthru Medicine focuses on aggressive solid tumors with the highest unmet need—cancers where patients have exhausted existing options. By attacking the specific molecular drivers of each tumor, we design precision therapies for patients whose cancers have become resistant to current treatments.
Investors 1
| Date | Name | Website |
| 15.02.2026 | Eshelman V... | eshelmanve... |
Mentions in press and media 1
| Date | Title | Description |
| - | Breakthru Medicine | “Home | Breakthru Medicine” |